Regeneron Pharmaceuticals | 销售和管理费用



Selling And Administration Expenses 更改 日
AbbVie USD 3.29B 562M 2025-03
Agios Pharmaceuticals USD 51.7M 13.16M 2024-12
Alnylam Pharmaceuticals USD 295.34M 74.35M 2024-12
Amgen USD 1.88B 253M 2024-12
Astellas Pharma JPY 211.32B 13.99B 2025-03
AstraZeneca USD 5.55B 307M 2024-12
Biogen USD 677.3M 99.6M 2024-12
BioMarin Pharmaceutical USD 256.77M 46.81M 2024-12
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Eli Lilly USD 2.42B 324.7M 2024-12
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.66B 1.14B 2024-12
Incyte USD 326.71M 17.5M 2024-12
Ionis Pharmaceuticals USD 88.08M 26.44M 2024-12
J&J USD 5.11B 1.34B 2025-03
Kyowa Hakko Kirin JPY 40.38B 2.68B 2024-09
Merck USD 2.53B 319M 2025-03
Moderna USD 351M 70M 2024-12
Neurocrine Biosciences USD 287.8M 53.5M 2024-12
Novartis USD 3.5B 368M 2024-12
Novartis USD 3.5B 368M 2024-12
Pfizer USD 4.27B 1.06B 2024-12
Regeneron Pharmaceuticals USD 792.2M 77.8M 2024-12
Roche Holding CHF 3.61B 381M 2024-12
Sanofi EUR 1.24B 1.44B 2024-12
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
Ultragenyx Pharmaceutical USD 82.49M 2.14M 2024-12
United Therapeutics USD 162.5M 8.4M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



Regeneron Pharmaceuticals 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Apr 2025.